Skip to main content

Pharmaceutical News and Articles

Comprehensive and up-to-date drug news for both consumers and healthcare professionals.

Long-Term Waterborne-Ingested Nitrate Linked to Prostate Cancer Risk

WEDNESDAY, March 29, 2023 -- Long-term waterborne-ingested nitrate is associated with an increased risk for prostate cancer, especially aggressive tumors...

BMI Impacts Long-Term Outcomes of Partial Knee Replacement

WEDNESDAY, March 29, 2023 -- Patients with higher body mass index (BMI) have higher revision rates for cemented unicompartmental knee replacements (UKRs), but...

Racial Disparities Seen for Pulmonary Fibrosis Outcomes

WEDNESDAY, March 29, 2023 -- Racial and ethnic-minority populations may experience disparities in pulmonary fibrosis (PF)-related outcomes, according to a...

Novel Risk Tool IDs Those at Risk for Contrast-Associated Acute Kidney Injury

WEDNESDAY, March 29, 2023 -- A novel risk assessment tool can be used preoperatively to identify patients at risk for contrast-associated acute kidney injury...

Vast Majority of Atrial Fibrillation Ablation Procedures Successful

WEDNESDAY, March 29, 2023 -- Successful pulmonary vein isolation is achieved in the majority of patients undergoing atrial fibrillation (AF) ablation, with a...

FDA Approves First Over-the-Counter Nasal Spray for Opioid Overdoses

WEDNESDAY, March 29, 2023 -- The U.S. Food and Drug Administration on Wednesday approved the over-the-counter use of a nasal spray that can reverse an opioid...

Could COVID in Pregnancy Raise Odds for Obese Kids?

WEDNESDAY, March 29, 2023 -- The consequences of COVID-19 during pregnancy are still unfolding, but a new study delivers sobering news: Prenatal exposure to...

Missed Getting Your Steps Today? You're Still on Track for Health

WEDNESDAY, March 29, 2023 -- For those who want to get active but feel that joining a gym or exercising on a daily basis is a bridge too far, new research may...

AHA News: Missouri Man Turns Heart Disease Diagnosis Into Public Service Message

WEDNESDAY, March 29, 2023 (American Heart Association News) -- Don Young already had been through an excruciating ordeal with throat cancer that included...

Too Much Time Online Might Raise Kids' Odds for Mental Health Woes: Study

WEDNESDAY, March 29, 2023 -- Children’s screen use could be altering their developing brains as they enter adolescence and increasing their risk for mood d...

FDA Approves Joenja (leniolisib) for the Treatment of Activated Phosphoinositide 3-Kinase Delta Syndrome (APDS)

LEIDEN, The Netherlands, March 24, 2023 /PRNewswire/ -- Pharming Group N.V. ("Pharming" or "the Company") (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) announces...

Biogen Provides Update on FDA Advisory Committee Meeting on Tofersen for SOD1-ALS

CAMBRIDGE, Mass., March 22, 2023 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) announced today the outcome of the U.S. Food and Drug Administration’s...

FDA Approves Rezzayo (rezafungin for injection) for the Treatment of Candidemia and Invasive Candidiasis

SAN DIEGO & PARSIPPANY, N.J.--(BUSINESS WIRE)-- March 22, 2023 -- Cidara Therapeutics, Inc. (Nasdaq: CDTX) and Melinta Therapeutics, LLC today announced...

FDA Approves Zynyz (retifanlimab-dlwr) for the Treatment of Metastatic or Recurrent Locally Advanced Merkel Cell Carcinoma (MCC)

WILMINGTON, Del.--(BUSINESS WIRE)--Mar. 22, 2023-- Incyte (Nasdaq:INCY) today announced that the U.S. Food and Drug Administration (FDA) has approved Zynyz...

FDA Approves First-in-class Evkeeza (evinacumab-dgnb) for Young Children with Ultra-Rare Form of High Cholesterol

TARRYTOWN, N.Y., March 22, 2023 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced the U.S. Food and Drug Administration (FDA)...

AbbVie Provides Regulatory Update on ABBV-951 (Foscarbidopa/Foslevodopa) New Drug Application

NORTH CHICAGO, Ill., March 22, 2023 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced it received a Complete Response Letter (CRL) from the U.S. Food and...

Sandoz Receives US FDA Approval for Biosimilar Hyrimoz (adalimumab-adaz) High-Concentration Formulation

Biosimilar Hyrimoz® (adalimumab-adaz) high-concentration formulation (HCF) approved for seven indications of reference medicine Humira®* With this...

Ionis Announces FDA Acceptance of New Drug Application for Eplontersen for the Treatment of Hereditary Transthyretin-Mediated Amyloid Polyneuropathy (ATTRv-PN)

35-week data included in the filing demonstrated a statistically significant and clinically meaningful change from baseline for co-primary and secondary...

Avadel Pharmaceuticals Requests Final FDA Approval for Lumryz (sodium oxybate) Extended-Release Oral Suspension

DUBLIN, Ireland, March 02, 2023 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to...

FDA Accepts for Priority Review ADX-2191 New Drug Application for the Treatment of Primary Vitreoretinal Lymphoma

LEXINGTON, Mass.--(BUSINESS WIRE) March 2, 2023 --Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) today announced that the U.S. Food and Drug...

Regeneron and Sonoma Biotherapeutics Announce Collaboration to Discover, Develop and Commercialize Treg Cell Therapies for Autoimmune Diseases

TARRYTOWN, N.Y., and SOUTH SAN FRANCISCO, Calif., March 28, 2023 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sonoma Biotherapeutics...

NIH Researchers Discover New Autoinflammatory Disease, Suggest Target for Potential Treatments

March 28, 2023 -- Scientists have identified an autoinflammatory disease caused by mutations in the LYN gene, an important regulator of immune responses in...

Trial Results for Ovarian Cancer will lead to new Standard of Care

MIAMI BEACH, Fla., March 28, 2023. Mount Sinai Medical Center (MSMC) is pleased to announce the results of a clinical trial led by Brian Slomovitz, MD...

Revolo Biotherapeutics Announces Completion of Phase 2a Trial of ‘1104 in Allergic Disease

NEW ORLEANS and CAMBRIDGE, England, March 27, 2023. Revolo Biotherapeutics (“Revolo Bio” or the “Company”), a company developing...

HIV Can Persist for Years in Myeloid Cells of People on Antiretroviral Therapy

March 27, 2023 -- A subset of white blood cells, known as myeloid cells, can harbor HIV in people who have been virally suppressed for years on...

Browse by news type

Drugs.com Newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.